SANTA CLARA, Calif., Apr 24, 2008 (BUSINESS WIRE) -- XenoPort, Inc. (Nasdaq:XNPT) announced today that it will provide
access via the World Wide Web to its presentation at the Morgan
Stanley Global Healthcare Unplugged Conference. The live presentation
will occur at 12:40 p.m. Pacific Time (3:40 p.m. Eastern Time) on
Thursday, May 1, 2008. A replay of the presentation will also be
To access the live presentation via the Web, please go to
www.XenoPort.com. Please connect to the Web site at least 15 minutes
prior to the live presentation to ensure adequate time for any
software downloads that may be necessary to listen to the Webcast.
A replay of the Webcast can be accessed for a minimum of one week
and will be available approximately 24 hours after the live
XenoPort, Inc. is a biopharmaceutical company focused on
developing a portfolio of internally discovered product candidates
that utilize the body's natural nutrient transport mechanisms to
improve the therapeutic benefits of existing drugs. Its development
and commercialization efforts are currently focused on potential
treatments of central nervous system disorders. XenoPort's most
advanced product candidate, XP13512, has successfully completed three
pivotal trials in its Phase 3 clinical program for the treatment of
moderate-to-severe primary restless legs syndrome and has successfully
completed a Phase 2a clinical trial for the management of
post-herpetic neuralgia. XenoPort has also reported positive results
from a Phase 2a clinical trial of its second product candidate,
XP19986, in patients with gastroesophageal reflux disease.
To learn more about XenoPort, please visit the Web site at
XenoPort is a registered U.S. trademark.
SOURCE: XenoPort, Inc.
Jackie Cossmon, 408-616-7220